Colony Bankcorp, Inc.
NYSE:CBANBanks - Regional
+$0.01 today
- Market cap
- $542.11M
- Beta
- 0.55
- P/E (TTM)
- 14.6
- EPS (TTM)
- $1.41
- Dividend yield
- 2.29%
Volume 0.25M
Average 0.31M
CBAN Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Colony Bankcorp, Inc.NYSE: CBAN
Accumulated OCI · Q1 FY2026 · quarter ended Mar 2026
Accumulated OCI remains negative
Q1 FY2026 Accumulated OCI was -$34.07M, compared with -$43.4M a year earlier.
Context
- Accumulated OCI amounted to 0.9% of total assets at the end of Q1 FY2026, down 0.5 pp from a year earlier.
- Accumulated OCI grew in size in 0 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps rising in the next quarterly balance sheet after a +21.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- (34.49M) USD
- Year-over-year change
- +27.5%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (34.49M) | +27.5% |
| FY2024 | 2024-12-31 | (47.57M) | +14.5% |
| FY2023 | 2023-12-31 | (55.64M) | +16.3% |
| FY2022 | 2022-12-31 | (66.44M) | -975.6% |
| FY2021 | 2021-12-31 | (6.18M) | — |
Accumulated OCI vs competitors
How CBAN compares with its peers on the latest reported figures
- CBAN's Mar 2026 Accumulated OCI of -$34.07M is the lowest of the 11 companies compared; the peer median is -$12.47M.
- Its year-over-year change of +21.5% is the 6th highest of 11, against a peer median of +21.7%.
- Accumulated OCI amounts to 0.9% of total assets for CBAN, versus a peer median of 0.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | -$350K | +47.8% | — | 0.0% | |
| Mar 2026 | -$6.29M | +42.3% | — | 0.2% | |
| Mar 2026 | -$7.53M | +18.7% | — | 0.3% | |
| Mar 2026 | -$8.6M | +50.7% | — | 0.4% | |
| Mar 2026 | -$11.82M | +16.8% | — | 0.5% | |
| Mar 2026 | -$13.11M | +38.3% | — | 0.6% | |
| Mar 2026 | -$13.29M | +19.2% | — | 0.6% | |
| Mar 2026 | -$15.75M | +7.3% | — | 0.5% | |
| Mar 2026 | -$24.76M | +24.3% | — | 0.8% | |
| Mar 2026 | -$32.59M | +15.1% | — | 1.0% | |
| Mar 2026 | -$34.07M | +21.5% | — | 0.9% | |
| Peer median (excluding CBAN) | -$12.47M | +21.7% | — | 0.5% | |
Competitors are the stored peer set for CBAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 18.98M | 20.58M | 25.34M | 26.05M | 27.31M |
| Short-term Investments | 938.16M | 432.55M | 407.38M | 38.8M | 225.19M |
| Net Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 957.14M | 453.14M | 432.72M | 64.85M | 252.5M |
| Property, Plant & Equipment (Net) | 43.03M | 41.61M | 39.87M | 37.83M | 37.05M |
| Goodwill | 52.91M | 48.92M | 48.92M | 48.92M | 63.87M |
| Intangible Assets | 7.39M | 5.66M | 4.19M | 2.98M | 7.85M |
| Long-term Investments | 1.38B | 2.22B | 2.36B | 2.64B | 3B |
| Tax Assets | 3.64M | 28.2M | 25.41M | 21.89M | 19.58M |
| Other Non-current Assets | 250.38M | 140.67M | 143.36M | 294.51M | 352.93M |
| Total Non-current Assets | 1.73B | 2.48B | 2.62B | 3.04B | 3.48B |
| Total Assets | 2.69B | 2.94B | 3.05B | 3.11B | 3.74B |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 5.31M | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.37B | 2.49B | 2.54B | 2.57B | 3.07B |
| Total Current Liabilities | 2.38B | 2.49B | 2.54B | 2.57B | 3.07B |
| Long-term Debt | 83.14M | 203.35M | 238.45M | 248.04M | 258.1M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 10.95M | 11.95M | 15.25M | 15.13M | 33.86M |
| Total Non-current Liabilities | 94.09M | 215.31M | 253.7M | 263.16M | 291.96M |
| Total Liabilities | 2.47B | 2.71B | 2.8B | 2.83B | 3.36B |
| Common Stock | 13.67M | 17.6M | 17.56M | 17.52M | 21.25M |
| Retained Earnings | 99.19M | 111.57M | 124.4M | 140.37M | 160.58M |
| Accumulated OCI | (6.18M) | (66.44M) | (55.64M) | (47.57M) | (34.49M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 217.71M | 230.27M | 254.94M | 278.68M | 375.92M |
| Total Debt | 88.45M | 203.35M | 238.45M | 248.04M | 258.1M |
| Net Debt | 69.47M | 182.77M | 213.11M | 221.99M | 230.8M |
Colony Bankcorp, Inc.
NYSE:CBAN
Intrinsic Alpha fair value
Locked
Current Price
$19.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.